Varex Imaging Corp VREX
We take great care to ensure that the data presented and summarized in this overview for Varex Imaging Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding VREX
View all-
Black Rock Inc. New York, NY7.15MShares$97.9 Million0.0% of portfolio
-
Richard Pzena Pzena Investment Management LLC3.89MShares$53.3 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$47.7 Million0.0% of portfolio
-
Allspring Global Investments Holdings, LLC2.55MShares$35 Million0.05% of portfolio
-
Cooke & Bieler LP2.28MShares$31.2 Million0.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.24MShares$30.7 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.66MShares$22.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$22.3 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.4MShares$19.1 Million0.17% of portfolio
-
Neuberger Berman Group LLC New York, NY1.2MShares$16.5 Million0.01% of portfolio
Latest Institutional Activity in VREX
Top Purchases
Top Sells
About VREX
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Insider Transactions at VREX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 20
2024
|
Kimberley E. Honeysett SVP and CLO |
SELL
Open market or private sale
|
Direct |
2,578
-90.36%
|
$30,936
$12.53 P/Share
|
Aug 15
2024
|
Shubham Maheshwari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,579
-8.77%
|
$90,948
$12.58 P/Share
|
Aug 15
2024
|
Shubham Maheshwari Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,315
+25.98%
|
-
|
Aug 12
2024
|
Shubham Maheshwari Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+15.14%
|
$100,000
$10.82 P/Share
|
Aug 09
2024
|
Shubham Maheshwari Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,007
+16.36%
|
$90,070
$10.98 P/Share
|
Mar 15
2024
|
Kimberley E. Honeysett SVP and CLO |
SELL
Open market or private sale
|
Direct |
2,860
-50.06%
|
$48,620
$17.37 P/Share
|
Feb 15
2024
|
Kimberley E. Honeysett SVP and CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,508
-31.56%
|
$42,636
$17.4 P/Share
|
Feb 15
2024
|
Kimberley E. Honeysett SVP and CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,086
+39.03%
|
-
|
Feb 15
2024
|
Andrew Hartmann SVP and GM, Detectors |
SELL
Payment of exercise price or tax liability
|
Direct |
2,429
-10.65%
|
$41,293
$17.4 P/Share
|
Feb 15
2024
|
Andrew Hartmann SVP and GM, Detectors |
BUY
Exercise of conversion of derivative security
|
Direct |
5,135
+18.37%
|
-
|
Feb 15
2024
|
Mark S. Jonaitis SVP and GM, X-Ray Sources |
SELL
Payment of exercise price or tax liability
|
Direct |
2,411
-3.84%
|
$40,987
$17.4 P/Share
|
Feb 15
2024
|
Mark S. Jonaitis SVP and GM, X-Ray Sources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,890
+7.23%
|
-
|
Feb 15
2024
|
Sunny Sanyal President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,520
-7.96%
|
$229,840
$17.4 P/Share
|
Feb 15
2024
|
Sunny Sanyal President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,223
+15.11%
|
-
|
Feb 11
2024
|
Jocelyn D Chertoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,881
+20.23%
|
-
|
Feb 11
2024
|
Walter M Rosebrough Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,881
+16.14%
|
-
|
Feb 11
2024
|
Timothy E Guertin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,881
+36.99%
|
-
|
Feb 11
2024
|
Jay K. Kunkel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,881
+27.13%
|
-
|
Feb 11
2024
|
Christine A Tsingos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,881
+19.96%
|
-
|
Dec 10
2023
|
Kimberley E. Honeysett SVP and CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,248
-44.01%
|
$42,712
$19.69 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 158K shares |
---|---|
Open market or private purchase | 19K shares |
Payment of exercise price or tax liability | 48.2K shares |
---|---|
Open market or private sale | 11.6K shares |